Trial Profile
Open-label, Multicenter Trial to Investigate the Pharmacokinetics of Aripiprazole IM Depot Fornulation (OPC-14597 IMD) by Repeated Dosing in Patients with Schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 01 Jun 2016 New trial record